RECOVER’s 2nd Round of Long COVID Clinical Trials Shows Progress… and Limitations
The RECOVER Initiative announces four more clinical trials for long COVID including low dose naltrexone, bariticinib, GLP-1 agonists, and stellate ganglion blockade.
Exertion Enhancer? Mestinon (Again) Moves the Needle on a Key Marker in ME/CFS
Mestinon improved handgrip strength - a key factor in overall health - in ME/CFS.
A Wake-Up Call for ME/CFS? The Solriamfetol / Sunosi Trial Improves Daytime Fatigue and Cognition
The small Sunosi ME/CFS trial improved daytime fatigue, planning and organizing, and symptoms.
Mast Cell Masterminds #1: The Pelvic Venous Syndromes and ME/CFS, POTS, and long COVID
Obstructions in the pelvic veins can contribute to diseases like POTS and ME/CFS and can be resolved using minimally invasive treatments.StudyME
Enroll in the OMF’s StudyME project and help bring about a cure for ME/CFS, fibromyalgia, POTS and long COVID.
